Sector valuations CellaVision AB OTC Markets
Stocks
CLVS.F
SE0000683484
Advanced Medical Equipment & Technology
|
Market Closed -
OTC Markets
12:52:56 2026-06-23 EDT
|
5-day change | 1st Jan Change | ||
| 14.00 USD | +3.78% |
|
-.--% | -16.80% |
| 09-15 | Cellavision's newly appointed CEO Stephen Ferguson makes his first share purchase for SEK 1.3m | FW |
| 09-14 | Lannebo Hälsa och Ny Teknik rose 5.9% in August, Bico among the month's winners | FW |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 65.11x | 5.77x | 0.94x | 5.09x | 17.02x | 28.3x | 0.32% | 17.66B | ||
| 43.29x | 5.64x | 0.48x | - | - | - | 1.87% | 1.87B | ||
| 14.95x | 2.55x | 3.04x | 2.04x | 6.93x | 8.45x | 1.72% | 879M | ||
| 39.45x | - | -0.31x | - | - | - | - | 781M | ||
| -2.69x | 0.45x | 0.04x | 1.37x | 6.32x | 12.11x | - | 761M | ||
| 114.54x | 2.83x | 0.67x | - | - | - | 1.02% | 560M | ||
| 33.65x | 1.97x | -0.86x | 2.86x | 17.06x | 18.22x | -.--% | 450M | ||
| -11.18x | - | 0.04x | - | - | - | - | 454M | ||
| 28.29x | 4.07x | -3.09x | 4.84x | 16.49x | 21.12x | 1.67% | 401M | ||
| 103.51x | 9.16x | -0.59x | 15.37x | 95.54x | 130.93x | - | 274M | ||
| 136.58x | 3.2x | -1.17x | 5.91x | 29.12x | 70.2x | - | 68.03M | ||
| Average | 51.41x | 3.96x | -0.07x | 5.35x | 26.93x | 41.33x | 1.1% | 2.2B | |
| Weighted average by Cap. | 57.78x | 5.31x | 0.76x | 4.91x | 17.27x | 27.99x | 0.55% |
- Stock Market
- Stocks
- CEVI Stock
- CLVS.F Stock
- Sector CellaVision AB
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















